Literature DB >> 21601606

"Wait and see" vaccinating behaviour during a pandemic: a game theoretic analysis.

Samit Bhattacharyya1, Chris T Bauch.   

Abstract

During the 2009 H1N1 pandemic, many individuals did not seek vaccination immediately but rather decided to "wait and see" until further information was available on vaccination costs. This behaviour implies two sources of strategic interaction: as more individuals become vaccinated, both the perceived vaccination cost and the probability that susceptible individuals become infected decline. Here we analyze the outcome of these two strategic interactions by combining game theory with a disease transmission model during an outbreak of a novel influenza strain. The model exhibits a "wait and see" Nash equilibrium strategy, with vaccine delayers relying on herd immunity and vaccine safety information generated by early vaccinators. This strategic behaviour causes the timing of the epidemic peak to be strongly conserved across a broad range of plausible transmission rates, in contrast to models without such adaptive behaviour. The model exhibits not only feedback mechanisms but also a feed-forward mechanism: a high initial perceived vaccination cost perpetuates high perceived vaccine costs (and lower vaccine coverage) throughout the remainder of the outbreak. This suggests that any effect of risk communication at the start of a pandemic outbreak will be amplified compared to the same amount of risk communication effort distributed throughout the outbreak.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601606     DOI: 10.1016/j.vaccine.2011.05.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  International society for disease surveillance conference 2011: building the future of public health surveillance.

Authors:  Daniel B Neill; Karl A Soetebier
Journal:  Emerg Health Threats J       Date:  2011-12-06

2.  Conscious consideration of herd immunity in influenza vaccination decisions.

Authors:  Andrew M Parker; Raffaele Vardavas; Christopher S Marcum; Courtney A Gidengil
Journal:  Am J Prev Med       Date:  2013-07       Impact factor: 5.043

3.  Decisions and disease: a mechanism for the evolution of cooperation.

Authors:  Carl-Joar Karlsson; Julie Rowlett
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

4.  Conflicts of interest during contact investigations: a game-theoretic analysis.

Authors:  Nicolas Sippl-Swezey; Wayne T Enanoria; Travis C Porco
Journal:  Comput Math Methods Med       Date:  2014-04-14       Impact factor: 2.238

Review 5.  Behavioural change models for infectious disease transmission: a systematic review (2010-2015).

Authors:  Frederik Verelst; Lander Willem; Philippe Beutels
Journal:  J R Soc Interface       Date:  2016-12       Impact factor: 4.118

6.  Dueling biological and social contagions.

Authors:  Feng Fu; Nicholas A Christakis; James H Fowler
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

Review 7.  Infection prevention behaviour and infectious disease modelling: a review of the literature and recommendations for the future.

Authors:  Dale Weston; Katharina Hauck; Richard Amlôt
Journal:  BMC Public Health       Date:  2018-03-09       Impact factor: 3.295

8.  What influenza vaccination programmes are preferred by healthcare personnel? A discrete choice experiment.

Authors:  Qiuyan Liao; Tiffany W Y Ng; Benjamin J Cowling
Journal:  Vaccine       Date:  2020-05-07       Impact factor: 3.641

9.  Outcome inelasticity and outcome variability in behaviour-incidence models: an example from an SEIR infection on a dynamic network.

Authors:  Bryce Morsky; Chris T Bauch
Journal:  Comput Math Methods Med       Date:  2012-12-05       Impact factor: 2.238

10.  Using experimental gaming simulations to elicit risk mitigation behavioral strategies for agricultural disease management.

Authors:  Eric M Clark; Scott C Merrill; Luke Trinity; Gabriela Bucini; Nicholas Cheney; Ollin Langle-Chimal; Trisha Shrum; Christopher Koliba; Asim Zia; Julia M Smith
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.